Biogen Inc (NASDAQ:BIIB)
| 274.48 Delayed Data As of Sep 18 |  -0.89 / -0.32%Today’s Change | 219.70 Today|||52-Week Range 374.99 | -7.50% Year-to-Date |
Latest BIIB News | Press Releases
Today’s Trading
| Previous close | 275.37 |
| Today’s open | 275.64 |
| Day’s range | 269.87 - 276.01 |
| Volume | 3,069,260 |
| Average volume (3 months) | 1,444,884 |
| Market cap | $43.5B |
Data as of 3:59pm ET, 09/18/2020
Growth & Valuation
| Earnings growth (last year) | +45.55% |
| Earnings growth (this year) | +3.72% |
| Earnings growth (next 5 years) | +0.37% |
| Revenue growth (last year) | +5.49% |
| P/E ratio | 8.1 |
| Price/Sales | 4.37 |
| Price/Book | 3.58 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ILMNIllumina Inc | -2.52 | -0.85% |
| MRNAModerna Inc | +1.98 | +2.92% |
| IMMUImmunomedics Inc | +0.19 | +0.22% |
| BMRNBiomarin Pharmaceuti... | +1.02 | +1.30% |
Data as of 6:33pm ET, 09/18/2020
Financials
| Next reporting date | October 21, 2020 |
| EPS forecast (this quarter) | $8.20 |
| Annual revenue (last year) | $12.7B |
| Annual profit (last year) | $5.9B |
| Net profit margin | 46.32% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
